PHGDH and neoplasm: The key enzyme in serine synthesis and SAM metabolism, PHGDH is a promising candidate and two PHGDH inhibitors, NCT-502 and NCT-503, have been shown to reduce tumor cell growth (Pacold et al., 2016; Rohde et al., 2018).